WO2017090869A1 - Injecteur de médicament pour maladie interne - Google Patents

Injecteur de médicament pour maladie interne Download PDF

Info

Publication number
WO2017090869A1
WO2017090869A1 PCT/KR2016/009756 KR2016009756W WO2017090869A1 WO 2017090869 A1 WO2017090869 A1 WO 2017090869A1 KR 2016009756 W KR2016009756 W KR 2016009756W WO 2017090869 A1 WO2017090869 A1 WO 2017090869A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug
gel
container
drug injector
injector
Prior art date
Application number
PCT/KR2016/009756
Other languages
English (en)
Korean (ko)
Inventor
차지현
김선욱
Original Assignee
차지현
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 차지현 filed Critical 차지현
Publication of WO2017090869A1 publication Critical patent/WO2017090869A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators

Definitions

  • This embodiment relates to a drug injector for internal diseases in which a gel-like agent is applied for the treatment of diseases occurring in the anus or cervix or vagina.
  • the tube or syringe-like container containing the gel-type drug is coupled to one end, and the gel-type drug provided therein is ejected into the anus or cervix or vagina through the spout formed in the body, but the gel-type drug is ejected. It is an object of the present invention to provide a drug injector for internal diseases in which the gel-type drug can be evenly applied over the entire direction of the anus or cervix or the vagina by allowing the fluid to flow along the guide formed on the outer circumferential surface of the body.
  • the drug injector for internal diseases the coupling portion is coupled to the tubular or syringe-type container containing the gel-type drug; And an injection part extending from the coupling part and ejecting the gel-type medicine provided from the container to the side, wherein the injection part has a cylindrical shape having a hollow formed therein and is inserted into the human body of the patient; A jet port formed in the body and the gel drug is ejected; It is formed along the outer circumferential surface of the body, and provides a drug injector for an internal disease, characterized in that it comprises a guide for providing a flow path of the gel-type drug ejected from the outlet.
  • the drug injector for internal diseases combines a tube or syringe-type container containing a gel-type drug to one end, and the gel-type drug provided through the spout formed in the body into the anus or cervix or vagina
  • the gel-type drug provided through the spout formed in the body into the anus or cervix or vagina
  • it is implemented in a form that allows the ejected gel-type drug flows along the guide portion formed on the outer circumferential surface of the body has an effect that can be evenly applied to the gel-like drug in the anus or cervix or vagina.
  • 1A is a view schematically showing a drug injector for internal diseases according to the first embodiment.
  • Figure 1b is a view showing a syringe-type container coupled to the internal disease drug injector according to the first embodiment.
  • FIG. 2 is a view schematically showing a drug injector for internal diseases according to the second embodiment.
  • FIG. 3 is a view schematically showing a drug injector for internal diseases according to the third embodiment.
  • Figure 4 is an exploded view showing the components of the drug injector for internal diseases according to the fourth embodiment.
  • FIG. 5 is a coupling diagram of the drug injector for internal diseases according to the fourth embodiment.
  • FIG. 6 is a longitudinal sectional view of the internal disease drug injector according to the fourth embodiment dissected in the axial direction.
  • FIG. 7 is a view illustrating a tubular container coupled to an internal disease drug injector according to a fourth embodiment.
  • FIG 8 is an axial view of the arm and the cancer joint of the drug injector for internal diseases according to the fourth embodiment.
  • 1A is a view schematically showing a drug injector for internal diseases according to the first embodiment.
  • the drug injector 100 for an internal disease includes an injection unit 110 and a coupling unit 120.
  • the injection part 110 is a part inserted into the human body, for example, the anus, the cervix, or the vagina, in order to apply a gel-type drug.
  • the injection part 110 according to the present embodiment extends from the coupling part 120 and is provided from a tubular or syringe-type container (hereinafter, to be described as a container) coupled to the coupling part 120. It is implemented in a form that can be ejected laterally.
  • the injection unit 110 includes a body 112, a jet port 114, and a guide unit 116.
  • the body 112 has a cylindrical shape with a hollow formed therein, and is a portion inserted into an anus, cervix, or vagina of an actual patient.
  • the body 112 employs a soft material to prevent damage to the inner wall of the anal or cervix or the vagina when the body 112 is inserted into the anal or cervix or the vagina, and the pain can be alleviated.
  • the body 112 may be manufactured by employing a material such as urethane or silicon.
  • the body 112 has one end corresponding to a direction (an anal or cervical or vaginal position direction) in which the patient's body is positioned during treatment of both ends with respect to the longitudinal direction of the body 112, thereby making the body ( 112 is formed for easier insertion into the anus or cervix or vagina.
  • the jet port 114 is formed in the body 112.
  • the jet port 114 may be formed on various positions of the body 112, and the number thereof may also be variously formed.
  • a plurality of ejection openings 114 may be formed along the longitudinal direction of the body 112 as shown in FIG. 1A.
  • the present embodiment is not limited to a specific position and a specific number with respect to the position and the number of the jet port 114 formed in the body 112.
  • the internal disease drug injector 100 when a user applies pressure to a container coupled to the internal disease drug injector 100, the gel-type drug contained in the container is injected into the anal or cervix through the spout 114. B is applied to the inner wall of the vagina. That is, the drug injector 100 for the internal disease is evenly applied to the anal or cervix or vagina as the gel-type drug provided from the container is ejected in a plurality of directions through the ejection opening 114 formed in the body 112. It can work.
  • the guide portion 116 may be formed in various shapes along the outer circumferential surface of the body 112.
  • the guide part 116 may have an outer circumferential surface of the body 112. It may be a groove formed along.
  • Guide portion 116 is formed with a guide portion 116 corresponding to each ejection opening 114 formed in the body 112, each of the guide portion 116 is connected to each other and one throughout the body 112 Form a flow path. That is, in the case of the internal disease drug injector 100 according to the first embodiment, each guide part 116 is connected to each other and has a spiral structure formed along the circumferential direction of the body 112.
  • the gel-type drug ejected from the ejection opening 114 may flow through the body 112. Through, there is an effect that can be more evenly applied to the gel-like drug in the anus or cervix or vagina.
  • Coupling unit 120 means a device for coupling of the container containing the gel-type drug.
  • the coupling portion 120 according to the present embodiment may be coupled to the tubular or syringe-type container depending on the application, but is not necessarily limited thereto.
  • Coupling unit 120 is provided with a coupling means for coupling of the container containing the gel-type drug.
  • the coupling part 120 may have a hole into which the inlet of the container is inserted to allow the container to be coupled onto the drug injector for internal disease.
  • the diameter of the hole has a size smaller than the diameter of the inlet of the container, it is made of a soft material can be implemented so that the inlet of the container having a size smaller than the diameter of the hole can be inserted into the hole.
  • the hole can be prevented from being separated from the drug injector 100 for the internal disease by firmly fixing the inlet of the container by the pressing force after the inlet of the container is inserted into the hole.
  • Coupling portion 120 may be implemented to have a tapered shape that widens in the direction in which the container is located.
  • the drug injector 100 for the internal disease according to the present embodiment is that the gel-type drug applied to the anus or the cervix or the vagina is often leaked to the outside of the anus or vagina during the procedure. While it can be prevented, there is an effect that can be applied to the gel-like drug in the anal or vaginal opening.
  • the coupling portion 120 is implemented in the form further provided with an auxiliary means for assisting the coupling of the container according to the type of container (ex: tubular container) coupled to the coupling portion 120 Can be.
  • An internal disease drug injector of another embodiment, in which an auxiliary means is additionally provided in the coupling unit 120, will be described in detail later in the process of describing an internal disease drug injector according to the fourth embodiment.
  • Figure 1b is a view showing a syringe-type container coupled to the internal disease drug injector according to the first embodiment.
  • the drug injector 100 for the internal disease according to the first embodiment is a device that is more specialized for the combination of the syringe-shaped container 130 having a standardized shape and size than the tubular container having various shapes and sizes. can do.
  • 1B illustrates a form in which the syringe-type container 130 is coupled to the internal disease drug injector 100 according to the first embodiment, but is not necessarily limited thereto, and the tubular container may also be combined. .
  • FIG. 2 is a view schematically showing a drug injector for internal diseases according to the second embodiment.
  • the internal disease drug injector 200 according to the second embodiment like the internal disease drug injector 100 according to the first embodiment, includes an injection unit 110 and a coupling unit 120. It consists of a shape comprising a.
  • the injection part 110 and the coupling part 120 of the internal disease drug injector 200 according to the second embodiment of the internal disease drug injector 100 according to the first embodiment have a basic function and shape. It is the same as the injection unit 110 and the coupling unit 120, a detailed description thereof will be omitted.
  • the guide part 116 may be formed in various shapes along the outer circumferential surface of the body 112. That is, in the case of the internal disease drug injector 200 according to the second embodiment, there is a difference in the shape of the guide unit 116 compared to the internal disease drug injector 100 according to the first embodiment.
  • Guide portion 116 is implemented in the shape of a groove formed along the outer peripheral surface of the body (112). At this time, the guide portion 116 is preferably formed to extend from the ejection opening 114 so that the gel-type drug ejected from the ejection opening 114 can flow more efficiently, but is not necessarily limited thereto.
  • Guide portion 116 is formed with a guide portion 116 corresponding to each ejection opening 114 formed in the body 112. Meanwhile, in the case of the internal disease drug injector 200 according to the second embodiment, the respective guide parts 116 are not connected to each other, and thus, each guide part 116 corresponds to each guide part 116. It provides a unique flow path for the gel-like agent ejected from the ejection port 114 to be.
  • the gel-type drug ejected from the ejection opening 114 flows along the outer circumferential surface of the body 112 to be anal or uterus. There is an effect that can be evenly applied to the inner wall of the neck or vagina.
  • generation of burrs due to the formation of the guide portion 116 of the internal disease drug injector 200 according to the first embodiment may be prevented.
  • Reduced body 112 has an effect that can be inserted more efficiently into the anal or cervical or vaginal.
  • FIG. 3 is a view schematically showing a drug injector for internal diseases according to the third embodiment.
  • the third shape of the guide part 116 will be described by exemplifying the internal disease drug injector 300 according to the third embodiment shown in FIG. 3.
  • Guide portion 116 may be implemented as a separate device formed along the outer circumferential surface of the body 112 on the outer surface of the body (112).
  • Guide portion 116 is formed with a guide portion 116 corresponding to each ejection opening 114 formed in the body 112, each of the guide portion 116 is connected to each other and one throughout the body 112 Form a flow path. That is, in the case of the internal disease drug injector 100 according to the third embodiment, each guide part 116 is connected to each other and has a spiral structure formed along the circumferential direction of the body 112.
  • Figure 4 is an exploded view showing the components of the drug injector for internal diseases according to the fourth embodiment.
  • the injection unit 110 of the internal disease drug injector 400 according to the fourth embodiment has the form of the injection unit 110 of the internal drug injector 400 according to the first embodiment. Illustrated as being, but not necessarily limited thereto.
  • the injection unit 110 of the internal disease drug injector 400 according to the fourth embodiment may be implemented in the form of the injection unit 110 of the internal drug injector for the second to third embodiments. .
  • the drug injector 400 for the internal disease is a device specialized in the coupling of the tubular container 150 rather than the syringe type container. It is implemented in a form that further includes an auxiliary coupling portion 140 for assisting.
  • a coupling groove 120a for connecting to the auxiliary coupling part 140 may be additionally formed on the coupling part 120.
  • the auxiliary coupling part 120 may include a ring 141, an arm 142, an arm joint 143, an end seal 144, and a handle 145. have.
  • the auxiliary coupling part 120 has an arm 142 for fixing the inlet of the tubular container 150 when the tubular container 150 is inserted.
  • Arm 142 is formed of a curved surface of the shape surrounding the inlet of the tubular container 150 is provided with a plurality of contact with the outer periphery of the inlet of the tubular container 150.
  • the auxiliary coupling part 120 has an arm joint 143 to support a plurality of arms.
  • the arm joint 143 is formed with a groove 143a into which the arm 142 is inserted, and the arm 142 is inserted therein.
  • the arm 142 also has a protrusion 142a and is connected to the coupling groove 120a.
  • Arm 142 employs a rigid plastic or metal.
  • the arm joint 143 is softer than the arm 142 and employs a flexible plastic or urethane, which is slightly elongated when the inlet of the tubular container 150 is inserted, and is designed to transmit a compressive force to the arm 142. .
  • Coupling portion 120 is inserted into the upper portion of the arm joint 143.
  • the ring 141 is inserted into the coupling gap between the coupling part 120 and the female joint 143 so that the gel-type drug does not leak.
  • the ring 141 uses a flexible material such as rubber, silicone, urethane, or the like.
  • the lower end of the arm joint 143 may be inserted into the inlet of the tubular container 150 and is attached to the end seal 144 that prevents the gel drug from leaking.
  • End seal 144 is also to use a soft polymer, silicone, urethane, rubber, other soft materials. The end seal 144 and the arm joint 143 are fastened so as not to be separated from each other using the handle 145.
  • the handle 145 is provided with a slip preventing protrusion 145a.
  • FIG. 5 is a coupling diagram of the drug injector for internal diseases according to the fourth embodiment.
  • FIG. 6 is a longitudinal sectional view of the internal disease drug injector according to the fourth embodiment dissected in the axial direction.
  • the arm 142 and the arm joint 143 surrounding the arm 142 are coupled to the lower end of the coupling part 120. At this time, the protrusion 142a provided in the arm 142 is inserted into the groove formed in the coupling part 120.
  • a ring 141 is inserted between the arm joint 143 and the coupling part 120 to prevent the gel drug from leaking.
  • the end seal 144 is coupled to the lower end of the arm joint 143 and the handle 145 for coupling the end seal 144 and the arm joint 143 is coupled.
  • the handle 145 is also used to join the end seal 144 and the arm joint 143, but is also used to smoothly rotate the internal injector drug injector 400 in a fully assembled state.
  • FIG. 7 is a view illustrating a tubular container coupled to an internal disease drug injector according to a fourth embodiment.
  • the end seal 144 of the flexible material is a tubular container Increased by the size of the entrance of 150.
  • the outer periphery of the inlet of the tubular container 150 is in contact with the arm 142 is fixed to the arm 142 by the pressing force transmitted by the arm joint 143.
  • the gel drug contained in the tubular container 150 is discharged through the outlet 114 of the injection unit 110. Exit and apply to the anus or the cervix or vagina. At this time, the gel drug is not leaked out by the ring 141 inserted between the arm joint 143 and the coupling part 120.
  • the end seal 144 also serves to prevent the gel drug leakage.
  • FIG 8 is an axial view of the arm and the arm joint according to the present embodiment.
  • Arm 142 is formed in a curved surface to surround the tubular container 150, a plurality, for example three are provided in contact with the outer periphery of the inlet of the tubular container 150.
  • the arm 142 which is a part directly contacting the inlet of the tubular container 150, is preferably made of a rigid material such as metal or plastic.
  • the arm joint 143 is made of a relatively soft material of plastic or urethane.
  • the arm joint 143 is manufactured in a form surrounding the arm 142 to transmit a compressive force to the arm 142 to allow the arm 142 to fix the tubular container 150.
  • the protrusion 142a provided in the arm 142 is inserted into the groove formed in the coupling part 120.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La présente invention concerne un injecteur de médicament pour une maladie interne, l'injecteur de médicament ayant une extrémité accouplée à un récipient tubulaire ou en forme de seringue contenant un médicament de type gel, et ayant le médicament de type gel qui est alimenté par le récipient éjecté dans un anus ou un col d'utérus ou un vagin par un orifice d'éjection situé sur un corps de ce dernier. Le médicament de type gel éjecté est laissé s'écouler le long d'une partie de guidage formée sur la surface circonférentielle extérieure du corps, ce qui permet au médicament de type gel d'être appliqué de manière uniforme à l'intérieur de l'anus ou du col de l'utérus ou du vagin.
PCT/KR2016/009756 2015-11-23 2016-09-01 Injecteur de médicament pour maladie interne WO2017090869A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150164343A KR101771894B1 (ko) 2015-11-23 2015-11-23 내부 질환용 약물 주입기
KR10-2015-0164343 2015-11-23

Publications (1)

Publication Number Publication Date
WO2017090869A1 true WO2017090869A1 (fr) 2017-06-01

Family

ID=58763303

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/009756 WO2017090869A1 (fr) 2015-11-23 2016-09-01 Injecteur de médicament pour maladie interne

Country Status (2)

Country Link
KR (1) KR101771894B1 (fr)
WO (1) WO2017090869A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2033296A (en) * 2022-10-12 2022-12-06 Suzhou Tcm Hospital Affiliated To Nanjing Univ Of Chinese Medicine A Syringe for A Medicament for Treating Constipation

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102200717B1 (ko) * 2020-05-25 2021-01-11 주식회사 에이치제이메디칼 마찰 스트레스 해소 및 공기 소통 기능이 있는 부인과 진료용 질 스페큘럼
KR102454902B1 (ko) * 2021-09-09 2022-10-21 주식회사 메드믹스 연고 도포 기능을 포함하는 광 조사 저주파 발생기
KR102454901B1 (ko) * 2021-09-09 2022-10-21 주식회사 메드믹스 연고 도포 기능을 구비하는 질 광 조사기
KR20230045475A (ko) 2021-09-28 2023-04-04 서형석 유기 게르마늄이 식품에 함유되는 식품 가열장치

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379341B1 (en) * 2000-07-24 2002-04-30 Goomi Ehwa Industries Co., Ltd. Syringe for vaginal irrigation
KR200400368Y1 (ko) * 2005-08-16 2005-11-03 주식회사 인성메디칼 항문 내부의 진통제 투입 기구
KR100763560B1 (ko) * 2005-08-17 2007-10-05 김경일 부인과 질환의 치료장치
WO2008043240A1 (fr) * 2006-10-09 2008-04-17 Min Zeng Dispositif destiné à une injection vaginale
KR200460550Y1 (ko) * 2009-10-30 2012-06-27 대한민국 소의 자궁 내 약물 주입장치
KR101352037B1 (ko) * 2011-12-23 2014-01-22 (주)메디탑 3통로식 발룬 카테타
KR101650181B1 (ko) * 2015-03-02 2016-08-23 차지현 항문질환약물 주입기

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379341B1 (en) * 2000-07-24 2002-04-30 Goomi Ehwa Industries Co., Ltd. Syringe for vaginal irrigation
KR200400368Y1 (ko) * 2005-08-16 2005-11-03 주식회사 인성메디칼 항문 내부의 진통제 투입 기구
KR100763560B1 (ko) * 2005-08-17 2007-10-05 김경일 부인과 질환의 치료장치
WO2008043240A1 (fr) * 2006-10-09 2008-04-17 Min Zeng Dispositif destiné à une injection vaginale
KR200460550Y1 (ko) * 2009-10-30 2012-06-27 대한민국 소의 자궁 내 약물 주입장치
KR101352037B1 (ko) * 2011-12-23 2014-01-22 (주)메디탑 3통로식 발룬 카테타
KR101650181B1 (ko) * 2015-03-02 2016-08-23 차지현 항문질환약물 주입기

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2033296A (en) * 2022-10-12 2022-12-06 Suzhou Tcm Hospital Affiliated To Nanjing Univ Of Chinese Medicine A Syringe for A Medicament for Treating Constipation

Also Published As

Publication number Publication date
KR20170059855A (ko) 2017-05-31
KR101771894B1 (ko) 2017-08-28

Similar Documents

Publication Publication Date Title
WO2017090869A1 (fr) Injecteur de médicament pour maladie interne
WO2015037832A1 (fr) Dispositif capillaire comprenant un filtre interne et dispositif d'injection de fluide le comprenant
WO2013129827A1 (fr) Outil auxiliaire pour coloscopie
WO2017200356A1 (fr) Support de tube médical
WO2023038372A1 (fr) Seringue pouvant évacuer une pression résiduelle
BRPI0903882A2 (pt) dispositivo aplicador pré-carregado
WO2018004267A1 (fr) Appareil d'injection de liquide dans le corps.
WO2012020913A2 (fr) Réservoir d'injection de lavement doté d'un tube ondulé
WO2017014405A1 (fr) Embout multiple permettant de relier un cathéter
WO2012020914A2 (fr) Réservoir d'injection de lavement doté d'un tube d'insertion pourvu d'une partie concave
CN218356936U (zh) 一种翻转式肛门给药装置
WO2019208926A1 (fr) Embout de tube d'injection de médicament liquide
WO2019151578A1 (fr) Ensemble de seringue jetable ayant une compatibilité améliorée
WO2017171179A1 (fr) Structure de raccordement pour tube de perfusion de kit d'administration
CN212817603U (zh) 一种阴道给药装置
KR101650181B1 (ko) 항문질환약물 주입기
CN111938559A (zh) 一种消化内科用新型肠窥镜
WO2011093626A2 (fr) Dispositif de cathéter pour lavement et procédé chirurgical l'employant
WO2021225215A1 (fr) Seringue comprenant une pointe de type facilement modifiable
CN211835581U (zh) 一种一次性保留灌肠管
WO2022231096A1 (fr) Adaptateur pour injecteur de médicament
WO2018093147A1 (fr) Ensemble de perfusion possédant une fonction de prévention d'une fuite de sang et d'un reflux
CN220714563U (zh) 一种新型推药器
CN215537716U (zh) 耳鼻喉科护理给药装置
CN213131509U (zh) 一种直肠用球囊管上药装置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16868770

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16868770

Country of ref document: EP

Kind code of ref document: A1